Warfarin-induced cutaneous necrosis is a rare complication of anticoagulant therapy with prevalence between 0.01 and 0.1%, associated to elevated morbimortality.
1 It occurs almost exclusively in patients with venous thrombosis and pulmonary embolism between the 1
st and the 10
th day after initiation of the anticoagulation. It has been associated to the deficiency of protein C and, more rarely, to the deficiency of protein S.
2